FMR »

Aardvark Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by FMR from 13F filings

Historical chart of FMR investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2025-12-31 $17k 1.3k 13.13
2025-09-30 $4.8k 363 13.29

More positions owned by FMR

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Netflix (NFLX)
Tesla Motors (TSLA)
Wells Fargo & Company (WFC)
Ge Aerospace Com New (GE)

View all positions for FMR

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Polygon Management
Geode Capital Management
Silverarc Capital Management
Two Sigma Investments
State Street Corporation
UBS Group
AQR Capital Management
Millennium Management
Northern Trust

View all funds holding Aardvark Therapeutics